Kingswood Wealth Advisors, LLC Purple Biotech Ltd. Transaction History

Kingswood Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	BUY	$0.41 - $0.86 $9,003 - $18,885	21,960 Added 11.8%	208,060 $84.7 Million
Q1 2024 Apr 15, 2024	BUY	$0.58 - $0.92 $6,380 - $10,120	11,000 Added 6.28%	186,100 $125 Million
Q4 2023 Jan 16, 2024	BUY	$0.78 - $1.67 $34,671 - $74,231	44,450 Added 34.02%	175,100 $137 Million
Q3 2023 Oct 23, 2023	BUY	$1.02 - $1.49 $2,754 - $4,023	2,700 Added 2.11%	130,650 $140 Million
Q2 2023 Aug 09, 2023	BUY	$1.38 - $2.05 $176,571 - $262,297	127,950 New	127,950 $178 Million

19.3K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $45.9M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Kingswood Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingswood Wealth Advisors, LLC with notifications on news.